Bioluminescence detection of proteolytic bond cleavage by using recombinant aequorin

Analytical Biochemistry

Volumn 281, Issue 1, 2000, Pages 87-94

  Deo, Sapna K ^a   Lewis, Jennifer C ^a   Daunert, Sylvia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aequorin; Bioluminescence; Bond cleavage assay; HIV 1 protease; Protease inhibitors

Indexed keywords

AMINO ACIDS; DRUG PRODUCTS; PHOSPHORESCENCE; POLYMERASE CHAIN REACTION; PROTEINS;

AEQUORIN; BIOPHARMACEUTICAL DRUGS; BOND CLEAVAGES; DOSE-RESPONSE CURVES; HIGH THROUGHPUT SCREENING; HIV-1 PROTEASE; PHOTOPROTEIN AEQUORIN; PROTEASE INHIBITOR;

BIOLUMINESCENCE;

ACETYL LEUCINE VALINE PHENYLALANINAL; ACETYL PEPSTATIN; AEQUORIN; PEPSTATIN; PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOLUMINESCENCE; COMPETITIVE INHIBITION; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; PROTEINASE INHIBITION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034658382     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.2000.4539     Document Type: Article

References (27)

1. Martin M. T., Angeles T. S., Sugasawara R., Aman N. I., Napper A. D., Darlsey M. J., Sanchez R. I., Booth P., Titmas R. C. Antibody-catalyzed hydrolysis of an unsubstituted amide. J. Am. Chem. Soc. 116:1994;6508-6512.
2. Jentsch S., Schlenker S. Selective protein degradation: A journey's end within the proteasome. Cell. 82:1995;881-884.
3. Kay J., Dunn B. M. Viral proteinases: Weakness in strength. Biochim. Biophys. Acta. 1048:1990;1-18.
4. Rawlings N. D., Barrett A. J. Evolutionary families of peptidases. Biochem. J. 290:1993;205-218.
5. Barrie K. A., Perez E. E., Lamers S. L., Farmerie W. G., Dunn B. M. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within Gag/Pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Virology. 219:1996;407-416.
6. Venturini A., Lopez-Ortiz F., Alvarez J. M., Gonzalez J. Theoretical proposal of a catalytic mechanism for the HIV-1 protease involving an enzyme-bound tetrahedral intermediate. J. Am. Chem. Soc. 120:1998;1110-1111.
7. Wlodawer A., Vondrasek J. Inhibitors of HIV-1 protease: A major success of structure-assisted drug design. Annu. Rev. Biophys. Biomol. Struct. 27:1998;249-284.
8. George C. H., Kendall J. M., Campbell A. K., Evans W. H. Connexin-aequorin chimerae report cytoplasmic calcium environments along trafficking pathways leading to gap junction biogenesis in living COS-7 cells. J. Biol. Chem. 273:1998;29822-29829.
9. Ramanathan S., Lewis J. C., Kindy M. S., Daunert S. Heterogeneous bioluminescence binding assay for an octapeptide using recombinant aequorin. Anal. Chim. Acta. 369:1998;181-189.
10. Crofcheck C. L., Grosvenor A. L., Anderson K., Lumpp J. K., Scott D., Daunert S. Detecting biomolecules in picoliter vials using aequorin bioluminescence. Anal. Chem. 69:1997;4768-4772.
11. Galvan B., Christopoulos T. K. Bioluminescence hybridization assays using recombinant aequorin: Application to the detection of prostate-specific antigen mRNA. Anal. Chem. 20:1996;3545-3550.
12. Billich S., Knoop M., Hansen J., Strop P., Sedlacek J., Mertz R., Moelling K. Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease. J. Biol. Chem. 263:1988;17905.
13. Njus D., Baldwin T., Hastings J. W. A sensitive assay for proteolytic enzymes using bacterial luciferase as a substrate. Anal. Biochem. 61:1974;280-287.
14. Darke P. L., Nutt R. F., Brady S. F., Garsku V. M., Ciccarone T. M., Leu C., Luma P. K., Freidinger R. M., Veber D. F., Sigal I. S. HIV-1 protease specificity of peptide cleavage is sufficient for processing of Gag and Pol polyproteins. Biochem. Biophys. Res. Commun. 156:1988;297.
15. Maniatis T., Fritsch D. F., Sambrook J. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
16. Horton R. M., Cai Z., Ho S. N., Pease L. R. Gene splicing by overlap extension: Tailor-made genes using the polymerase chain reaction. Biotechniques. 8:1990;528-535.
17. Huang W., Wang J., Bhattacharyya D., Bachas L. G. Improving the activity of immobilized subtilisin by site-specific attachment to surfaces. Anal. Chem. 69:1997;4601-4607.
18. Nashed N. T., Louis J. M., Sayer J. M., Wondrak E. M., Mora P. T., Oroszlan S., Jerina D. M. Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV. Biochem. Biophys. Res. Commun. 163:1989;1079-1085.
19. Tomaszek T. A. Jr., Maggard V. W., Bryan H. G., Moore M. L., Meek T. D. Chromophoric peptide substrates for the spectrophotometric assay of HIV-1 protease. Biochem. Biophys. Res. Commun. 168:1990;274-280.
20. Matayoshi E. D., Wang G. T., Kraft G. A., Erickson J. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science. 247:1990;954-958.
21. Fournot S., Roquet F., Salhi S. L., Seyer R., Valverde V., Masson J. M., Jouin P., Pau B., Nicolas M., Hanin V. Development and standardization of an immuno-quantified solid phase assay for HIV-1 aspartyl protease activity and its application to the evaluation of inhibitors. Anal. Chem. 69:1997;1746-1752.
22. Wang, J, Ensor, C. M, Dubuc, G. J, Narang, S. A, and, Daunert, S. 1999, Fusion proteins of single-chain antibody and photoproteins for assay development in the detection of Salmonella antigen, 218th National ACS Meeting, Spring, 1999.
23. Inouye S., Sakaki Y., Goto T., Tsuji F. Expression of apoaequorin complementary DNA in Escherichia coli. Biochemistry. 25:1986;8425-8429.
24. Buttner J., Dornmair K., Schramn H. J. Screening of inhibitors of HIV-1 protease using an Escherichia coli cell assay. Biochem. Biophys. Res. Commun. 233:1997;36-38.
25. Stella S., Saddler G., Sarubbi E., Colombo L., Stefanelli S., Denaro M., Selva E. Isolation of α-MAPI from fermentation broths during a screening program for HIV-1 protease inhibitors. J. Antibiot. 44:1991;1019-1022.
26. Richards A., Roberts R., Dunn B., Graves M., Kay J. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases. FEBS Lett. 247:1989;113-117.
27. Sarubbi E., Seneci P. F., Angelastro M. R., Peet N. P., Denaro M., Islam K. Peptide aldehydes as inhibitors of HIV protease. FEBS Lett. 319:1993;253-256.